Bridging traditional botanical pharmacology and precision medicine via molecular screening, GMP pilot isolation, and multi-phase clinical validation.
Strategic market analysis on the shift from crude herbal powders to high-purity single isolates, standardized fingerprints, and clinical dossiers.
Global regulatory bodies (FDA 21 CFR Part 111, EMA botanical monographs) no longer tolerate uncharacterized herbal mixtures. International buyers demand validated chromatographic profiles (HPLC, HPTLC) verifying consistent pharmacological yield per milligram.
Tier-1 nutraceutical and pharmaceutical formulators routinely face supply disruptions caused by crop seasonality, solvent residue restrictions, and pesticide variations. Single-point integrated supply lines mitigate cross-continental compliance failure.
Phytotherapy candidates require robust preclinical proof: cellular pathway clarification, acute/chronic toxicology, pharmacokinetics (PK/PD), and human safety trials before market entrance or pharmaceutical NDA submissions.
Combining traditional geographic authenticity (Daodi) with automated bioprocessing, closed-loop extraction, and automated continuous purification pipelines.
MedGence (Yineng Pharma) operates high-throughput extraction lines utilizing continuous countercurrent extraction, macroporous resin adsorption columns, and membrane separation technologies. This automation ensures volatile bioactive compounds (flavonoids, polyphenols, saponins, alkaloids) avoid thermal degradation, maintaining bioactivity identical to native botanical matrices.
Pilot plants directly transition formulations into multi-metric ton commercial scale with zero batch parameter slippage. Our closed-loop system monitors pH, temperature, flow rates, and spectral absorptions in real time.
From botanical authentication via chromatographic fingerprinting to ultra-trace residue screening (pesticides, heavy metals, aflatoxins, PAH/plasticizers via LC-MS/MS and GC-MS), our Changsha central testing facility fulfills rigorous Western pharmacopeial targets (USP, Ph. Eur., JP).
A rigorous, linear developmental cycle engineered to reduce market approval friction for pharmaceutical, nutraceutical, and clinical dermatological clients.
Systematic screening of complex plant secondary metabolites. High-content phenotypic screening and computational bio-affinity tools identify target hits for metabolic, anti-inflammatory, or cognitive targets.
Assaying dynamic concentration variances across harvest altitudes, climatic variations, and growth phases to build sustainable, economically resilient raw ingredient sourcing blueprints.
Development and inter-laboratory validation of quantitative HPLC, GC, and HPTLC methods. Establishment of unique chromatographic fingerprints to combat adulteration.
Pilot-scale refinement of solid-liquid ratio, extraction cycles, solvent recovery, and specialized spray drying parameters to guarantee crystalline stability and active yield consistency.
Execution of GLP-compliant LD50 evaluations, sub-acute toxicity, Ames tests, and in vitro cellular mechanism elucidation to substantiate clean toxicological portfolios.
Bridging translational data with randomized, double-blind human clinical trials (Phase I–IV) to create irrefutable structure-function claims or support pharmaceutical dossier filings.
Engineered for rapid integration into dietary supplements, pharmaceutical dosage forms, functional beverages, and clinical dermaceuticals.
Our processing lines deliver active ingredients calibrated to specific volumetric densities, dissolvability indices, and hygroscopicity tolerances:
Cleanroom packaging and dosage delivery systems operating under international GMP conditions for seamless market commercialization:
Decades of contract analytical and process engineering trusted by major pharmaceutical manufacturers and university clinical hospitals.
Tongrentang Group
CR Sanjiu Medical
Sunflower Pharma
Livzon Pharma Group
Dihon Pharmaceutical
Golden Throat Group
Yangtzi River Pharma
Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Pharma
Shandong Hanfang
Luoxin Pharma Group
Zhongsheng Pharma
Brilliance Abundance
Apeloa Pharmaceutical
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Guangxi Santo
Kangshou Pharma
Juwang Pharma
Beijing Tcmages
Guizhou Ruihe
CR Jinchan Pharma
Kangmei Pharma
Tianjicaotang Pharma
Kingstone Unite
Shuguang Hospital
Hunan Affiliated TCM
First Hospital Hunan TCM
Second Xiangya Hospital
Second Hospital Hunan TCM
Zhuzhou Orthopedics TCM
Direct responses addressing chromatography, safety qualification, regulatory compliance, and CDMO confidentiality.
Connect directly with our scientific team to deploy verified botanical active screening, process development, and commercial supply lines.
